Company
Newsroom.
Our press releases provide you with detailed information about Ottobock's products, social responsibility and global presence. Learn about the latest technologies and current highlights in the medical technology sector. As a company that conducts research, we feature numerous interesting topics.
Press releases.
Friday, 26 September 2025
Ottobock supports India's largest para-sporting event
Over 1,000 athletes compete for medals / Ottobock offers technical support and Wheelchair Experience World / Exclusive interview about para sports in India
Over 1,000 athletes compete for medals / Ottobock offers technical support and Wheelchair Experience World / Exclusive interview about para sports in India
Saturday, 6 September 2025
Ottobock helps secure Paralympic Games dreams
The medtech company will be attending the Milano Cortina 2026 Paralympic Winter Games as a technical partner
The medtech company will be attending the Milano Cortina 2026 Paralympic Winter Games as a technical partner
Wednesday, 3 September 2025
Invisible Class: Invisible borders for over 1.3 billion travellers
Through its new campaign, Ottobock aims to highlight the barriers that people with disabilities encounter when travelling and demonstrate how they can travel independently.
Through its new campaign, Ottobock aims to highlight the barriers that people with disabilities encounter when travelling and demonstrate how they can travel independently.
Wednesday, 27 August 2025
Ottobock expands treatment options in orthopaedic workshops
Hydrostatic casting and UV light technology are strengthening the O&P Business Solutions division
Hydrostatic casting and UV light technology are strengthening the O&P Business Solutions division
Thursday, 21 August 2025
Ottobock with strong H1 2025 results: Innovation drives profitable growth
Successful implementation of the growth strategy with strategic product launches and numerous acquisitions; significant improvement in EBITDA margins through economies of scale and efficiency gains
Revenue increased to EUR 801 million (H1 2024: EUR 763 million), up 5.0% (organic growth: 10.0%)
Underlying EBITDA increased by 30.5% to EUR 180 million (H1 2024: EUR 138 million); underlying EBITDA margin of 22.5% (H1 2024: 18.1%)
Successful implementation of the growth strategy with strategic product launches and numerous acquisitions; significant improvement in EBITDA margins through economies of scale and efficiency gains
Revenue increased to EUR 801 million (H1 2024: EUR 763 million), up 5.0% (organic growth: 10.0%)
Underlying EBITDA increased by 30.5% to EUR 180 million (H1 2024: EUR 138 million); underlying EBITDA margin of 22.5% (H1 2024: 18.1%)
5 results out of 286